{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-009508","form_type":"8-K","ticker":"CBIO","cik":"0001253689","company_name":"CRESCENT BIOPHARMA, INC.","filed_at":"2024-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.632926+00:00","generated_at":"2026-06-01T01:20:33.379767+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"GlycoMimetics receives Nasdaq bid price deficiency notice; 180 days to regain compliance","bullets":["Received Nasdaq notice on June 21, 2024 for bid price below $1.00 for 30 consecutive business days.","Has until December 18, 2024 to regain compliance by closing at $1.00+ for 10 consecutive days.","If not compliant, may transfer to Nasdaq Capital Market for an additional 180-day compliance period.","Failure to regain compliance could result in delisting of GLYC common stock from Nasdaq.","Company intends to monitor bid price and consider options; no assurance of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-009508","json":"https://secwatch.observer/filing/0001558370-24-009508.json","markdown":"https://secwatch.observer/filing/0001558370-24-009508.md","text":"https://secwatch.observer/filing/0001558370-24-009508.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1253689/000155837024009508/0001558370-24-009508-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1253689/000155837024009508/glyc-20240621x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:20:33.379767+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}